2016
Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients
Alsaleh A, Gaidos JK, Kang L, Kuemmerle JF. Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients. Digestive Diseases And Sciences 2016, 61: 2602-2607. PMID: 27126205, PMCID: PMC4982818, DOI: 10.1007/s10620-016-4171-9.Peer-Reviewed Original ResearchMeSH KeywordsAbdominal AbscessAdolescentAdultAnastomotic LeakChildColitis, UlcerativeCrohn DiseaseDigestive System Surgical ProceduresFemaleGastrointestinal AgentsHumansIleusInflammatory Bowel DiseasesInfliximabIntestinal ObstructionMaleMiddle AgedPostoperative ComplicationsPreoperative CareReoperationRetrospective StudiesRisk FactorsSurgical Wound InfectionTime FactorsVenous ThromboembolismYoung AdultConceptsLast preoperative dosePostoperative complicationsInflammatory bowel diseasePreoperative doseLast doseUlcerative colitisCrohn's diseaseInflammatory bowel disease patientsMethodsRetrospective chart reviewBowel disease patientsResultsNo significant associationIBD patientsPreoperative statusChart reviewPreoperative useBackgroundThe associationBowel diseaseSurgeon typeSurgery typeSteroid useDisease patientsInfliximabComplicationsPatientsDisease typeHow to Optimize Colon Cancer Surveillance in Inflammatory Bowel Disease Patients
Gaidos JK, Bickston SJ. How to Optimize Colon Cancer Surveillance in Inflammatory Bowel Disease Patients. Inflammatory Bowel Diseases 2016, 22: 1219-1230. PMID: 26926040, DOI: 10.1097/mib.0000000000000685.Peer-Reviewed Original ResearchConceptsInflammatory bowel disease patientsBowel disease patientsColonic Crohn's diseaseColorectal neoplasiaUlcerative colitisDisease patientsCurrent surveillance guidelinesDuration of diseasePrimary sclerosing cholangitisExtent of diseaseOverall high riskColon cancer surveillanceColonic IBDColorectal dysplasiaSclerosing cholangitisSurveillance colonoscopyConcomitant diagnosisCrohn's diseaseSporadic colon cancerChronic inflammationSociety guidelinesSurveillance guidelinesCancer surveillanceRisk factorsFamily history
2015
Timing of Last Preoperative Dose of Anti-Tumor Necrosis Factor α Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients
Gaidos J, Alsaleh A, Kuemmerle J. Timing of Last Preoperative Dose of Anti-Tumor Necrosis Factor α Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients. The American Journal Of Gastroenterology 2015, 110: s797. DOI: 10.14309/00000434-201510001-01877.Peer-Reviewed Original Research